Turning the key on p53
- 1 February 2004
- journal article
- Published by Springer Nature in Nature
- Vol. 427 (6977) , 789-790
- https://doi.org/10.1038/427789a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating PeptidePLoS Biology, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- News In BriefNature Medicine, 2004
- Mdm2 Regulates p53 Independently of p19ARF in Homeostatic TissuesMolecular and Cellular Biology, 2004
- Inhibiting the p53–MDM2 interaction: an important target for cancer therapyNature Reviews Cancer, 2003
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003
- mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing IrradiationMolecular and Cellular Biology, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53Nature, 1995
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979